iBio Reports Fiscal Second Quarter 2025 Financial Results
GlobeNewswire· 2025-02-10 21:05
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), today reported financial results for the second quarter ended Dec. 31, 2024, and provided a corporate update on its progress. “In our second fiscal quarter we further strengthened our leadership with key Board appointments, reinforcing our commitment to innovation and execution as we work to develop next-generation therapeutics,” said CEO and Chief Scientific Officer Dr. Martin Brenner, Ph.D. “Following more recent developments, we also w ...
Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended December 31, 2024 of $0.049 Per Unit
GlobeNewswire· 2025-02-10 21:05
ATHENS, Greece, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a quarterly cash distribution with respect to the quarter ended December 31, 2024 of $0.049 per unit. The cash distribution is payable on or about February 27, 2025 to all unit holders of record as of February 24, 2025. About Dynagas LNG Partners LP Dynagas LNG Partners LP (NYSE: DLNG) is a master limited ...
PetMeds® Announces Third Quarter Fiscal 2025 Financial Results
GlobeNewswire· 2025-02-10 21:05
DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on ...
Stryker announces Allan Golston will retire from Board of Directors
GlobeNewswire· 2025-02-10 21:05
Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for re-election at Stryker's 2025 Annual Meeting of Shareholders, which is expected to be held on May 8, 2025. Golston joined Stryker’s Board of Directors in 2011 and served as independent Lead Director from 2016 to 2022. He also served on the Governance and Nominating Committee and as Chair of the Compensation and ...
CTO Realty Growth Announces Fourth Quarter 2024 Earnings Release and Conference Call Information
GlobeNewswire· 2025-02-10 21:05
WINTER PARK, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the fourth quarter and full year 2024 after the market closes on Thursday, February 20, 2025. A conference call to discuss its financial and operating results is scheduled for Friday, February 21, 2025 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at www.ctoreit.com ...
Fluence Energy, Inc. Reports First Quarter 2025 Results; Lowers Full Year 2025 Guidance; Reports Record $5.1 Billion Backlog
GlobeNewswire· 2025-02-10 21:05
ARLINGTON, Va., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months ended December 31, 2024. Financial Highlights for Fiscal Quarter ended December 31, 2024 Revenue of approximately $186.8 million, which represents a decrease of approximately 49% from the same quarter last year, primarily driven b ...
SPS Commerce Reports Fourth Quarter and Fiscal Year 2024 Financial Results
GlobeNewswire· 2025-02-10 21:05
Company delivers 96th consecutive quarter of topline growth Fourth quarter 2024 revenue grew 18% and recurring revenue grew 19% from the fourth quarter of 2023 MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced financial results for the fourth quarter and year ended December 31, 2024. Financial Highlights Fourth Quarter 2024 Financial Highlights Revenue was $170.9 million in the fourth quarter of 2024, compared to ...
PennantPark Investment Corporation Announces Financial Results for the Quarter Ended December 31, 2024
GlobeNewswire· 2025-02-10 21:05
MIAMI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (NYSE: PNNT) announced today its financial results for the first quarter ended December 31, 2024. HIGHLIGHTS Quarter ended December 31, 2024 (unaudited)($ in millions, except per share amounts) Assets and Liabilities: Investment portfolio (1) $1,298.1 Net assets $494.3 GAAP net asset value per share $7.57 <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; ver ...
Outbrain to Release Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
GlobeNewswire· 2025-02-10 21:05
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), which is operating under the new Teads brand, today announced that the company will release its fourth quarter and full year 2024 results before the market opens on Thursday, February 27, 2025, followed by a conference call at 8:30 a.m. (Eastern Time) that same day to discuss the company’s results and business outlook. The conference call can be accessed live over the phone by dialing 1-877-497-9071 or for international callers, 1-201-6 ...
Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire· 2025-02-10 21:03
BOSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced the closing of its upsized initial public offering of 12,176,467 shares of its common stock at a public offering price of $18.00 per share, which incl ...